Volume 65, Issue 6, Pages (June 2004)

Slides:



Advertisements
Similar presentations
Volume 70, Issue 1, Pages (July 2006)
Advertisements

Volume 67, Issue 2, Pages (February 2005)
Volume 66, Issue 1, Pages (July 2004)
Volume 74, Issue 3, Pages (August 2008)
Volume 73, Issue 11, Pages (June 2008)
Kuo-Jung Li, Ai-Li Shiau, Yuan-Yow Chiou, Yi-Te Yo, Chao-Liang Wu 
Volume 63, Issue 6, Pages (June 2003)
Boye L. Jensen, Bianca Mann, Ole Skøtt, Armin Kurtz 
Human renal epithelial cells produce the long pentraxin PTX3
Volume 58, Issue 5, Pages (November 2000)
Volume 78, Issue 10, Pages (November 2010)
Volume 68, Issue 6, Pages (December 2005)
Volume 63, Issue 6, Pages (June 2003)
Volume 65, Issue 5, Pages (May 2004)
Volume 66, Issue 6, Pages (December 2004)
Volume 58, Issue 6, Pages (December 2000)
Volume 74, Issue 3, Pages (August 2008)
Volume 63, Issue 5, Pages (May 2003)
Cytochrome P450 2E1 null mice provide novel protection against cisplatin-induced nephrotoxicity and apoptosis  Hua Liu, Radhakrishna Baliga  Kidney International 
Mechanisms of the proteinuria induced by Rho GTPases
Volume 67, Issue 4, Pages (April 2005)
Volume 66, Issue 5, Pages (November 2004)
Volume 56, Issue 5, Pages (November 1999)
Animal Model of Sclerotic Skin
Volume 64, Issue 5, Pages (November 2003)
Relaxin in cardiovascular and renal disease
Volume 79, Issue 5, Pages (March 2011)
Volume 63, Issue 4, Pages (April 2003)
Volume 65, Issue 6, Pages (June 2004)
Hiroyuki Yanagisawa, Nobuyuki Yamazaki, Gen Sato, Osamu Wada 
PPARα agonist fenofibrate improves diabetic nephropathy in db/db mice
Volume 63, Issue 4, Pages (April 2003)
1,25-dihydroxyvitamin D3 inhibits renal interstitial myofibroblast activation by inducing hepatocyte growth factor expression  Yingjian Li, Bradley C.
Volume 70, Issue 1, Pages (July 2006)
Volume 67, Issue 2, Pages (February 2005)
Volume 65, Issue 6, Pages (June 2004)
Volume 60, Issue 2, Pages (August 2001)
Volume 79, Issue 10, Pages (May 2011)
Volume 57, Issue 3, Pages (March 2000)
Volume 56, Issue 4, Pages (October 1999)
Volume 67, Issue 1, Pages (January 2005)
Volume 65, Issue 2, Pages (February 2004)
Volume 63, Issue 2, Pages (February 2003)
Volume 66, Issue 1, Pages (July 2004)
Mitochondrial dysfunction in focal segmental glomerulosclerosis of puromycin aminonucleoside nephrosis  M. Hagiwara, K. Yamagata, R.A. Capaldi, A. Koyama 
Volume 63, Issue 1, Pages (January 2003)
Volume 68, Issue 2, Pages (August 2005)
Increased endothelin-1 expression in the kidney in hypercalcemic rats
Volume 69, Issue 11, Pages (June 2006)
Volume 56, Issue 5, Pages (November 1999)
Volume 64, Issue 3, Pages (September 2003)
Volume 58, Issue 2, Pages (August 2000)
Volume 67, Issue 6, Pages (June 2005)
Ganesan Ramesh, W. Brian Reeves  Kidney International 
Laminin-8/9 is synthesized by rat glomerular mesangial cells and is required for PDGF- induced mesangial cell migration  Kim Hansen, Christine K. Abrass 
H. Raffi, J.M. Bates, Z. Laszik, S. Kumar  Kidney International 
Volume 65, Issue 4, Pages (April 2004)
Volume 56, Issue 6, Pages (December 1999)
Volume 64, Issue 1, Pages (July 2003)
Lin Mu, Ph. D. , Wei Zheng, Ph. D. , M. D. , Liang Wang, Ph. D
Cultured human glomerular mesangial cells express the C5a receptor
The Relaxin Gene Knockout Mouse: A Model of Progressive Scleroderma
Wanfen Xiong, MD, PhD, Rebecca Knispel, BS, Jason Mactaggart, MD, B
Volume 58, Issue 6, Pages (December 2000)
Steven Ledbetter, Leslie Kurtzberg, Sineaid Doyle, Bruce M. Pratt 
Effect of age and biopsy site on extracellular matrix mRNA and protein levels in human kidney biopsies  Michael Eikmans, Hans J. Baelde, Emile De Heer,
Volume 65, Issue 5, Pages (May 2004)
Volume 60, Issue 5, Pages (November 2001)
Volume 65, Issue 6, Pages (June 2004)
Volume 70, Issue 1, Pages (July 2006)
Presentation transcript:

Volume 65, Issue 6, Pages 2054-2064 (June 2004) Relaxin-1–deficient mice develop an age-related progression of renal fibrosis  Chrishan S. Samuel, Chongxin Zhao, Courtney P. Bond, Tim D. Hewitson, Edward P. Amento, Roger J. Summers  Kidney International  Volume 65, Issue 6, Pages 2054-2064 (June 2004) DOI: 10.1111/j.1523-1755.2004.00628.x Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 1 Effects of relaxin deficiency on kidney dry weight (A), collagen content (B), and collagen types (C) in aging mice. The dry weight of the separated kidney cortex (C) and medulla (M) of male RLX+/+ and RLX-/- mice (from 1month to 12months of age) and female mice (from 1month to 19months of age) was measured, along with the total collagen content from the same tissues at each age group. Total collagen content was derived from the sum of collagen in the cortex and medulla. The numbers in parenthesis represent number of samples. *P < 0.05 and #P < 0.01, when compared with corresponding values from age-matched RLX+/+ mice. The pepsin-digested collagen, which shows the maturely cross-linked insoluble collagen types was analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), using delayed reduction of the disulfide bonds with 10%β-mercaptoethanol. The samples consist of a type I/III collagen standard from human dermis and the collagen from two individual pepsin digests from the cortex and medulla of RLX+/+ and RLX-/- mice, respectively. Four RLX+/+ and four RLX-/- mouse cortex and medulla extracts were analyzed by SDS-PAGE and gave identical results. Kidney International 2004 65, 2054-2064DOI: (10.1111/j.1523-1755.2004.00628.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 2 Effects of relaxin deficiency on kidney histology. Hematoxylin and eosin staining of whole kidney sections from RLX+/+ (A) and RLX-/- (B) mice were performed to compare tissue size and structure. Kidney sections from RLX-/- mice were larger in size than those of RLX+/+ mice and contained thicker cortices. Masson trichrome staining was used to identify matrix (collagen) within the cortical interstitium (C and D) and glomeruli (E and F) of RLX+/+ and RLX-/- mice, respectively. Quantitative analysis of staining indicated focal increases in interstitial matrix (D) and diffuse increased glomerular matrix (F) in RLX-/- mice. rH2-treatment of RLX-/- mice resulted in a marked decreased in collagen staining within the interstitial tubules (G) and glomeruli (H), as compared to staining observed in untreated (D and F) and vehicle alone–treated mouse kidney sections. Kidney International 2004 65, 2054-2064DOI: (10.1111/j.1523-1755.2004.00628.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 3 Reverse transcription-polymerase chain reaction (RT-PCR) of relaxin-1, relaxin-3, and LGR7 mRNA expression in immature (1month) and adult (9months) RLX+/+ and RLX-/- mouse kidney tissues. Ethidium bromide-stained PCR products of mouse relaxin-1 (150bp), relaxin-3 (319bp) and LGR7 (178bp) are shown, while glyceraldehyde-3-phosphate dehydrogenase (GAPDH) products (246bp) were used as controls for quality and equal loading of the cDNA. Samples consist of a molecular weight marker and duplicate samples from the 1-month-old cortex, 9-month-old cortex, 1-month-old medulla, and 9-month-old medulla of RLX+/+ and RLX-/- mice, respectively. cDNA from the pregnant mouse ovary was used as a positive control for relaxin-1, while mouse brain and/or cortex were used as positive controls for relaxin-3 and LGR7. Water replaced cDNA in negative control reactions for each PCR. Kidney International 2004 65, 2054-2064DOI: (10.1111/j.1523-1755.2004.00628.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 4 Effects of relaxin deficiency on total glomerular protein and collagen expression. The glomeruli were isolated from kidney tissues of RLX+/+ and RLX-/- mice and analyzed for differences in protein content and hydroxyproline (collagen) content. Glomerular protein and collagen expression in RLX-/- mouse samples was expressed as a ratio of protein or collagen in RLX+/+ mouse tissues, respectively, which was always expressed as 1. The numbers in parenthesis represent number of sample analyzed. *P < 0.05; #P < 0.01, when compared with corresponding values from RLX+/+ mice. Kidney International 2004 65, 2054-2064DOI: (10.1111/j.1523-1755.2004.00628.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 5 Effects of relaxin deficiency on serum creatinine and total urine protein. To determine if the effects of relaxin deficiency on kidney structure and collagen were associated with changes in kidney function, serum creatinine and total urinary protein excretion (over a 24-hour period) were measured in RLX+/+ and RLX-/- mice. Numbers in parenthesis represent number of samples used in each assay. *P < 0.05, when compared with corresponding values from age-matched RLX+/+ mice. Kidney International 2004 65, 2054-2064DOI: (10.1111/j.1523-1755.2004.00628.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 6 Effects of rH2 treatment on the kidney of RLX-deficient mice. Total collagen content from the kidney cortex and medulla of 12-month-old RLX+/+ mice, untreated RLX-/- mice, vehicle alone–treated RLX-/- mice, and 0.5mg/kg/day rH2-treated RLX-/- mice is shown. Total collagen content was derived from the sum of collagen content in the cortex and medulla of each tissue. Numbers in parenthesis represent number of mice used from each group. *P < 0.05 whencompared with aged-matched untreated and vehicle-treated RLX-/- mouse collagen levels; #P < 0.05 when compared with total collagen from age-matched RLX+/+ mouse kidneys. Kidney International 2004 65, 2054-2064DOI: (10.1111/j.1523-1755.2004.00628.x) Copyright © 2004 International Society of Nephrology Terms and Conditions